PL374082A1 - Karnityna w leczeniu depresji wieku podeszłego - Google Patents
Karnityna w leczeniu depresji wieku podeszłegoInfo
- Publication number
- PL374082A1 PL374082A1 PL03374082A PL37408203A PL374082A1 PL 374082 A1 PL374082 A1 PL 374082A1 PL 03374082 A PL03374082 A PL 03374082A PL 37408203 A PL37408203 A PL 37408203A PL 374082 A1 PL374082 A1 PL 374082A1
- Authority
- PL
- Poland
- Prior art keywords
- carnitine
- treatment
- geriatric depression
- geriatric
- depression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35432302P | 2002-02-07 | 2002-02-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL374082A1 true PL374082A1 (pl) | 2005-09-19 |
Family
ID=27734357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03374082A PL374082A1 (pl) | 2002-02-07 | 2003-01-23 | Karnityna w leczeniu depresji wieku podeszłego |
Country Status (10)
Country | Link |
---|---|
US (1) | US20040009926A1 (pl) |
EP (1) | EP1471904A1 (pl) |
JP (1) | JP2005523269A (pl) |
KR (1) | KR20040083471A (pl) |
AR (1) | AR038350A1 (pl) |
AU (1) | AU2003219511A1 (pl) |
CA (1) | CA2469925A1 (pl) |
MX (1) | MXPA04007506A (pl) |
PL (1) | PL374082A1 (pl) |
WO (1) | WO2003066041A1 (pl) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050272812A1 (en) * | 2002-02-07 | 2005-12-08 | Pettegrew Jay W | Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans |
US7407778B2 (en) | 2002-02-07 | 2008-08-05 | Pettegrew Jay W | Compounds, compositions and methods for treating neuropsychiatric disorders |
US7700074B2 (en) | 2002-02-07 | 2010-04-20 | Pettegrew Jay W | Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism |
CN1795198B (zh) | 2003-05-29 | 2011-08-17 | 杰伊·W·佩特格尤 | 对神经精神疾病进行医学成像所用的甘油磷酸胆碱及其衍生物 |
EP2582368B1 (en) | 2010-06-16 | 2018-05-09 | Alfasigma S.p.A. | Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue |
US11135181B2 (en) | 2014-10-28 | 2021-10-05 | Medlab Ip Pty Ltd | Treatment for depression and depressive disorders |
US11918336B2 (en) * | 2019-02-19 | 2024-03-05 | King Abdullah University Of Science And Technology | Reduced feature generation for signal classification based on position weight matrix |
US20230181475A1 (en) | 2020-05-15 | 2023-06-15 | Alfasigma S.P.A. | Composition comprising methylfolate |
WO2023084531A1 (en) * | 2021-11-12 | 2023-05-19 | Celagenex Research (India) Pvt. Ltd. | A synergistic composition for activating intracellular secondary messenger(camp) pathway |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4346107A (en) * | 1979-02-12 | 1982-08-24 | Claudio Cavazza | Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism |
US5208037A (en) * | 1991-04-22 | 1993-05-04 | Alza Corporation | Dosage forms comprising polymers comprising different molecular weights |
US5879884A (en) * | 1994-12-29 | 1999-03-09 | Peroutka; Stephen J. | Diagnosis of depression by linkage of a polymorphic marker to a segment of chromosome 19P13 bordered by D19S247 and D19S394 |
JP3425276B2 (ja) * | 1995-08-11 | 2003-07-14 | 株式会社日立製作所 | 情報通知システム |
JPH10143640A (ja) * | 1996-11-15 | 1998-05-29 | Nippon Lsi Card Kk | 携帯コンピュータ及びそれを用いた情報管理システム並びにそれを用いた立体地図の作成方法 |
US5889055A (en) * | 1997-04-04 | 1999-03-30 | Howard; James R. | L-carnitine and acetyl-L-carnitine combined for prevention and treatment of syndromes related to diseases of energy metabolism |
-
2003
- 2003-01-23 EP EP03715324A patent/EP1471904A1/en not_active Withdrawn
- 2003-01-23 AU AU2003219511A patent/AU2003219511A1/en not_active Abandoned
- 2003-01-23 MX MXPA04007506A patent/MXPA04007506A/es unknown
- 2003-01-23 JP JP2003565465A patent/JP2005523269A/ja active Pending
- 2003-01-23 KR KR10-2004-7009147A patent/KR20040083471A/ko not_active Application Discontinuation
- 2003-01-23 PL PL03374082A patent/PL374082A1/pl unknown
- 2003-01-23 WO PCT/IT2003/000023 patent/WO2003066041A1/en active Application Filing
- 2003-01-23 CA CA002469925A patent/CA2469925A1/en not_active Abandoned
- 2003-02-05 AR ARP030100356A patent/AR038350A1/es unknown
- 2003-02-07 US US10/359,560 patent/US20040009926A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003066041A1 (en) | 2003-08-14 |
KR20040083471A (ko) | 2004-10-02 |
AU2003219511A1 (en) | 2003-09-02 |
MXPA04007506A (es) | 2004-11-10 |
EP1471904A1 (en) | 2004-11-03 |
CA2469925A1 (en) | 2003-08-14 |
JP2005523269A (ja) | 2005-08-04 |
AR038350A1 (es) | 2005-01-12 |
US20040009926A1 (en) | 2004-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24662A (en) | Purine compounds and uses thereof | |
GB0206033D0 (en) | Compounds useful in therapy | |
SG104356A1 (en) | Absorbent body and absorbent article having the absorbent body | |
GB0225065D0 (en) | Multiple use impression coping | |
TWI348380B (en) | Cleansing cosmetic | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
EP1543034A4 (en) | TREATMENT AND PROPHYLAXIS WITH 4-1BB BINDING AGENTS | |
AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
EP1581243A4 (en) | ORAL LACTOFERRINE FOR THE TREATMENT OF SEPSIES | |
AU2001265186A1 (en) | Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions | |
PL374082A1 (pl) | Karnityna w leczeniu depresji wieku podeszłego | |
GB0223570D0 (en) | Surface treatment | |
IL165112A0 (en) | Variant integrinpolypeptides and thereof | |
EP1541174A4 (en) | MEDICINE OR COSMETIC PRODUCT | |
SG110107A1 (en) | Compound and use in treatment | |
EP1501722A4 (en) | IMPROVEMENTS IN THE BEAUPRES | |
MY137954A (en) | Absorbent structure and absorbent article comprising the absorbent structure | |
AU2003228355A8 (en) | Adipocytes and uses thereof | |
AU2003293500A1 (en) | Lactoferrin in the reduction of pain | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
AU2003217432A8 (en) | Angiopoietin-1 in the treatment of disease | |
AU2003244437A1 (en) | Quinoxalinones and their use especially in the treatment of cardiovascular diseases | |
ZA200509171B (en) | Hydroxamic acids useful in the treatment of hyperproliferative disorders | |
GB0203528D0 (en) | Process and composition | |
GB0318162D0 (en) | Polishes and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |